Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: neuroprotective agents (Click to remove) Head Injury JNNP 56:440-447, Miller,J.D., 1993 Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study Lancet 372:1463-1472, Kappos,L.,et al, 2008 Guidelines for the Early Management of Patients with Ischemic Stroke Stroke 36:916-921, Adams,H.,et al, 2005 Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis Brain 126:433-437, Filippi,M.,et al, 2003 New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies Neurol 57:S48-S52, Warach,S., 2001 Characterizing the Target of Acute Stroke Therapy Stroke 28:866-872, Fisher,M., 1997 Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial Lancet 383:2213-2221, Chataway, J.,et al, 2014 Guidelines for the Early Management of Patients with Ischemic Stroke Stroke 34:1056-1083, Adams,H.P.,et al, 2003 A 60-Year-Old Man with Parkinson's Disease JAMA 275:716-722, Olanow,C.W., 1996 Guidelines for the Management of Patients with Acute Ischemic Stroke Stroke 25:1901-1914, Adams,H.P.,et al, 1994 Evolving Toward Effective Therapy for Acute Ischemic Stroke JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993 Effect of Nimodipine on Cerebral Infarction & Outcome after Subarachnoid Haemorrhage:British Aneurysm Nimodipine Trial BMJ 298:636-642, Pickard,J.D.,et al, 1989 Showing articles 0 to 12 of 12